Production and titering of recombinant adeno-associated viral vectors

Journal of Visualized Experiments

Volumn , Issue 57, 2011, Pages

  McClure, Christina ^a   Cole, Katy L H ^a   Wulff, Peer ^a   Klugmann, Matthias ^b   Murray, Andrew J ^a,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

AAV; Adeno associated virus; Immunology; Issue 57; Stereotaxic injection; Viral gene transfer; Virus titer

Indexed keywords

EID: 83455195422     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3348     Document Type: Article

References (23)

1. Klugmann, M., et al. AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Molecular and Cellular Neurosciences. 28, 347-60 (2005).
2. Murray, A.J., et al. Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nature Neuroscience. 14, 297-299 (2011).
3. Hippenmeyer, S., et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biology. 3, e159 (2005).
4. Hauck, B. Generation and characterization of chimeric recombinant AAV vectors. Molecular Therapy. 7, 419-425 (2003).
5. Halbert, C.L., Allen, J.M., & Miller, A. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. Journal of Virology. 75, 6615 (2001).
6. Blankinship, M.J., et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Molecular Therapy. 10, 671-8 (2004).
7. Wu, Z., et al. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. Journal of Virology. 80, 11393-7 (2006).
8. Dong, J.Y., Fan, P.D., & Frizzell, R.A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Human gene therapy. 7, 2101-12 (1996).
9. Zolotukhin, S., et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods. 28, 158-67 (2002).
10. Burova, E. & Loffe, E. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Therapy. 12 Suppl 1, S5-17 (2005).
11. Zolotukhin, S., et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy. 6, 973-985 (1999).
12. Bilbao, R., et al. Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1. Human Gene Therapy. 16, 678-84 (2005).
13. Pilpel, N., et al. Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. Journal of Neuroscience Methods. 182, 55-63 (2009).
14. Mastakov, M.Y., et al. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Molecular Therapy. 3, 225-32 (2001).
15. Fu, H., et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Molecular Therapy. 8, 911-7 (2003).
16. Ghosh, A., Yue, Y., & Duan, D. Efficient Transgene Reconstitution with Hybrid Dual AAV Vectors Carrying the Minimized Bridging Sequences. Human Gene Therapy. 22, 77-83 (2011).
17. McCarty, D.M. Self-complementary AAV vectors; advances and applications. Molecular Therapy. 16, 1648-56 (2008).
18. Georgiadis, A., et al. AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins. Gene Therapy. 17, 486-93 (2010).
19. Atasoy, D., et al. A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. The Journal of Neuroscience. 28, 7025-30 (2008).
20. Guggenhuber, S., et al. AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity. PLoS One. 5, e15707 (2010).
21. Lawlor, P.A., et al. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Molecular therapy: the journal of the American Society of Gene Therapy. 17, 1692-702 (2009).
22. Chtarto, A., et al. Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Therapy 10, 84-94 (2003).
23. Han, Y., et al. Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors. Gene Therapy. 17, 616-25 (2010).